Skip to main content

Table 4 The association between rs11064, rs1045241 and rs1045242 and clinicopathological characteristics of endometrial cancer

From: Association of TNFAIP8 gene polymorphisms with endometrial cancer in northern Chinese women

Characteristics

rs11064

P a

rs1045241

P a

rs1045242

P a

AA

AG

GG

AG + GG

CC

CT

TT

CC + CT

AA

AG

GG

AG + GG

FIGO stage

    

0.011

    

0.174

    

0.103

 I

108

60

10

70

0.425

115

54

9

63

0.075

114

58

6

64

0.041

 II

23

6

3

9

 

22

8

2

10

 

24

7

1

8

 

 III–IV

7

4

5

9

 

6

9

1

10

 

6

9

1

10

 

Histologic grade

    

0.718

    

0.678

    

0.658

 G1

56

29

5

34

0.966

57

28

5

33

0.554

56

30

4

34

0.383

 G2

60

29

11

40

 

66

28

6

34

 

68

29

3

32

 

 G3

22

12

2

14

 

20

15

1

16

 

20

15

1

16

 

Histological type

    

0.445

    

0.469

    

0.464

 EC

112

57

17

74

1.000

114

61

11

72

0.182

116

62

8

70

 

 Non-EC

26

13

1

14

 

29

10

1

11

 

28

12

0

12

 

Depth of MI

    

0.047

    

0.153

    

0.088

 < 50%

95

53

17

70

0.077

98

98

8

65

0.114

97

60

6

66

0.034

 ≥ 50%

43

17

1

18

 

45

45

4

18

 

47

14

2

16

 

LVSI

    

0.708

    

0.338

    

0.562

 No

118

63

16

79

0.350

122

122

10

75

0.274

123

67

7

74

0.297

 Yes

20

7

2

9

 

21

21

2

8

 

21

7

1

8

 

LN metastasis

    

0.048

    

0.702

    

0.934

 No

122

62

12

74

0.351

123

123

10

73

0.679

124

65

7

72

0.718

 Yes

16

8

6

14

 

20

20

2

10

 

20

9

1

10

 

CA-125 level

    

0.261

    

0.296

    

0.115

 ≤ 35 U/mL

102

59

14

73

0.113

108

108

8

67

0.283

106

63

6

69

0.063

 > 35 U/Ml

36

11

4

15

 

35

35

4

16

 

38

11

2

13

 

P53

    

0.198

    

0.092

    

0.141

 Negative

75

34

13

47

0.890

83

31

8

39

0.108

84

33

5

38

0.082

 Positive

63

36

5

41

 

60

40

4

44

 

60

41

3

44

 

ER

    

0.631

    

0.516

    

0.706

 Negative

33

16

6

22

0.853

36

18

1

19

0.630

34

20

1

21

0.736

 Positive

105

54

12

66

 

107

53

11

66

 

110

54

7

61

 

PR

    

0.604

    

0.860

    

0.439

 Negative

49

20

6

26

0.353

49

23

3

26

0.651

49

22

4

26

0.722

 Positive

89

50

12

62

 

94

48

9

57

 

95

52

4

56

 

Ki67

    

0.47

    

0.117

    

0.704

 Negative

34

14

6

20

0.743

33

20

1

21

0.854

32

20

2

22

0.435

 Positive

104

56

12

68

 

110

51

11

66

 

112

54

6

60

 
  1. FIGO International Federation of Gynecology and Obstetrics, G1 well, G2 moderate, G3 poor, EC endometrial cancer, MI myometrial invasion, LVSI lymphovascular space involvement, LN lymph node
  2. aTwo-sided Chi-squared test or Fisher’s test